ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.

Jürgen Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.